MedPath

Severe anaphylaxis caused by intravenous anti-cancer drugs

Not Applicable
Conditions
Severe Anaphylaxis
Registration Number
JPRN-UMIN000042887
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5584
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of severe anaphylaxis that was caused by anti-cancer medications
Secondary Outcome Measures
NameTimeMethod
high-risk situation
© Copyright 2025. All Rights Reserved by MedPath